Tadalafil 5 mg once-daily therapy for men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: Results from a randomized, double-blind, placebo-controlled trial carried out in Japan and Korea

Autor:	Sung Won Lee, Osamu Yokoyama, Yoji Morisaki, Lars Viktrup, Masayuki Takeda, Masahiro Murakami
Rok vydání:	2014
Předmět:	medicine.medical_specialty business.industry Urology Placebo-controlled study Hyperplasia medicine.disease Placebo Tadalafil Double blind Tolerability Lower urinary tract symptoms medicine International Prostate Symptom Score business medicine.drug
Zdroj:	International Journal of Urology. 21:670-675
ISSN:	0919-8172
Popis:	Objectives To gain further evidence on the efficacy, safety and tolerability of tadalafil 5 mg once-daily in Asian men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Methods Japanese and Korean men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia were randomized to once-daily tadalafil 5 mg (n = 306) or placebo (n = 304) for 12 weeks. Results A significantly greater improvement (P
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6f0e44fffe97089788ec62055216c0f9 https://doi.org/10.1111/iju.12410 Zobrazit plný text záznamu Plný text ve formátu PDF Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.